Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share (ALLO)

Q: What does CUSIP 019770106 represent in this 13F holders report?

CUSIP 019770106 is the security identifier for ALLO - Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held ALLO - Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share in Q1 2019?

85 institutional investors reported ALLO - Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share for Q1 2019. Use the holders table for investor-level position and value details.

CUSIP: 019770106

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 344,793,745
Total 13F shares: 65,390,655
Share change: +2,711,207
Total reported value: $1,661,573,471
Put/Call ratio: 99%
Price per share: $28.91
Number of holders: 85
Value change: +$80,500,361
Number of buys: 47
Number of sells: 31

Quarterly Holders Quick Answers

What is CUSIP 019770106?
CUSIP 019770106 identifies ALLO - Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2019
Previous quarter: Q4 2018

Recent filing periods for CUSIP 019770106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ALLO - Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
TPG Group Holdings (SBS) Advisors, Inc.	13F	Company	6.7%	23,135,061	$623,027,000	—	31 Dec 2018	13F
FMR LLC	13F	Company	1.4%	4,910,987	$130,492,000	—	31 Dec 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.73%	2,511,998	$65,888,000	—	31 Dec 2018	13F
Capital Research Global Investors	13F	Company	0.73%	2,507,188	$62,590,000	—	31 Dec 2018	13F
Capital World Investors	13F	Company	0.63%	2,171,483	$58,478,000	—	31 Dec 2018	13F
BlackRock Finance, Inc.	13F	Company	0.6%	2,079,829	$56,011,000	—	31 Dec 2018	13F
VANGUARD GROUP INC	13F	Company	0.59%	2,046,329	$55,107,000	—	31 Dec 2018	13F
Capital International Investors	13F	Company	0.59%	2,031,554	$54,710,000	—	31 Dec 2018	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.45%	1,543,790	$41,574,000	—	31 Dec 2018	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.37%	1,285,427	$34,617,000	—	31 Dec 2018	13F
Avoro Capital Advisors LLC	13F	Company	0.33%	1,128,584	$27,753,000	—	31 Dec 2018	13F
WADDELL & REED FINANCIAL INC	13F	Company	0.29%	1,016,000	$27,361,000	—	31 Dec 2018	13F
JENNISON ASSOCIATES LLC	13F	Company	0.24%	830,092	$22,185,000	—	31 Dec 2018	13F
DSAM Partners (London) Ltd	13F	Company	0.19%	649,607	$17,494,000	—	31 Dec 2018	13F
PFM Health Sciences, LP	13F	Company	0.18%	617,193	$16,621,000	—	31 Dec 2018	13F
FRANKLIN RESOURCES INC	13F	Company	0.14%	499,182	$13,443,000	—	31 Dec 2018	13F
LORD, ABBETT & CO. LLC	13F	Company	0.12%	402,002	$10,826,000	—	31 Dec 2018	13F
Artal Group S.A.	13F	Company	0.12%	400,000	$10,772,000	—	31 Dec 2018	13F
NORGES BANK	13F	Company	0.12%	400,000	$10,772,000	—	31 Dec 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.11%	370,618	$9,981,000	—	31 Dec 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.1%	355,911	$9,585,000	—	31 Dec 2018	13F
STATE STREET CORP	13F	Company	0.1%	354,792	$9,555,000	—	31 Dec 2018	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.09%	326,797	$8,801,000	—	31 Dec 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.09%	319,068	$8,592,000	—	31 Dec 2018	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.09%	298,977	$8,051,000	—	31 Dec 2018	13F
NORTHERN TRUST CORP	13F	Company	0.08%	286,240	$7,709,000	—	31 Dec 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.08%	269,424	$7,256,000	—	31 Dec 2018	13F
Coastal Bridge Advisors, LLC	13F	Company	0.05%	181,000	$4,874,000	—	31 Dec 2018	13F
FEDERATED HERMES, INC.	13F	Company	0.05%	175,000	$4,713,000	—	31 Dec 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.04%	152,871	$4,117,000	—	31 Dec 2018	13F
SAMLYN CAPITAL, LLC	13F	Company	0.04%	150,000	$4,039,000	—	31 Dec 2018	13F
MACQUARIE GROUP LTD	13F	Company	0.04%	146,779	$3,953,000	—	31 Dec 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.04%	144,127	$3,882,000	—	31 Dec 2018	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.04%	131,000	$3,528,000	—	31 Dec 2018	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.03%	113,437	$3,055,000	—	31 Dec 2018	13F
FIRST TRUST ADVISORS LP	13F	Company	0.03%	101,441	$2,732,000	—	31 Dec 2018	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.03%	95,822	$2,580,486	—	31 Dec 2018	13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.03%	87,966	$2,369,000	—	31 Dec 2018	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.02%	64,300	$1,732,000	—	31 Dec 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	61,287	$1,650,000	—	31 Dec 2018	13F
Vident Investment Advisory, LLC	13F	Company	0.02%	60,682	$1,634,000	—	31 Dec 2018	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.01%	50,000	$1,347,000	—	31 Dec 2018	13F
J.P. Morgan Private Wealth Advisors LLC	13F	Company	0.01%	44,000	$1,185,000	—	31 Dec 2018	13F
SHIKIAR ASSET MANAGEMENT INC	13F	Company	0.01%	39,200	$1,056,000	—	31 Dec 2018	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	38,715	$1,043,000	—	31 Dec 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	37,300	$1,003,000	—	31 Dec 2018	13F
MORGAN STANLEY	13F	Company	0.01%	36,731	$990,000	—	31 Dec 2018	13F
Bank of New York Mellon Corp	13F	Company	0.01%	34,968	$941,000	—	31 Dec 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	34,877	$939,000	—	31 Dec 2018	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	30,788	$829,000	—	31 Dec 2018	13F

Institutional Holders of Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share (ALLO) as of Q1 2019

As of 31 Mar 2019, Allogene Therapeutics, Inc. - Common Stock, $0.001 par value per share (ALLO) was held by 85 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 65,390,655 shares. The largest 10 holders included TPG Group Holdings (SBS) Advisors, Inc., VV Manager LLC, FMR LLC, Capital Research Global Investors, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Capital World Investors, VANGUARD GROUP INC, Capital International Investors, and PERCEPTIVE ADVISORS LLC. This page lists 85 institutional shareholders reporting positions in this security for the Q1 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders

Q1 2019 holders

Holder diff

Investor	Q4 2018 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q4 2018 Value $	Q1 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.